Jane Street’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-24,368
| Closed | -$491K | – | 11156 |
|
|
2021
Q3 | $491K | Sell |
24,368
-4,718
| -16% | -$130K | ﹤0.01% | 7307 |
|
|
2021
Q2 | $1.09M | Buy |
29,086
+18,494
| +175% | +$567K | ﹤0.01% | 5655 |
|
|
2021
Q1 | $271K | Sell |
10,592
-18,426
| -63% | -$471K | ﹤0.01% | 7844 |
|
|
2020
Q4 | $639K | Sell |
29,018
-179,572
| -86% | -$3.96M | ﹤0.01% | 5365 |
|
|
2020
Q3 | $3.75M | Buy |
208,590
+186,678
| +852% | +$3.87M | ﹤0.01% | 2183 |
|
|
2020
Q2 | $557K | Sell |
21,912
-7,450
| -25% | -$160K | ﹤0.01% | 4917 |
|
|
2020
Q1 | $539K | Buy |
29,362
+5,235
| +22% | +$102K | ﹤0.01% | 3552 |
|
|
2019
Q4 | $532K | Buy |
+24,127
| New | +$486K | ﹤0.01% | 3619 |
|
|
2019
Q2 | – | Sell |
-10,412
| Closed | -$153K | – | 5995 |
|
|
2019
Q1 | $153K | Buy |
+10,412
| New | +$120K | ﹤0.01% | 4713 |
|
|
2018
Q2 | – | Sell |
-14,262
| Closed | -$136K | – | 5848 |
|
|
2018
Q1 | $136K | Buy |
+14,262
| New | +$154K | ﹤0.01% | 4544 |
|
|
2016
Q3 | – | Sell |
-10,274
| Closed | -$31K | – | 4713 |
|
|
2016
Q2 | $31K | Buy |
+10,274
| New | +$42.2K | ﹤0.01% | 3976 |
|
Other funds holding DRNA
Jane Street's DRNA Position: Q4 2021 in Review
Jane Street sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 24,368 shares — an estimated $491K sold.
Jane Street first reported a position in DRNA in Q2 2016 and held it in 11 quarters. The position peaked at $3.75M in Q3 2020. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.
- Jane Street reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
- Jane Street sold 24,368 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $491K.
- Jane Street first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2016 and held it in 11 quarters.
- Jane Street's Dicerna Pharmaceuticals, Inc. position peaked at $3.75M in Q3 2020.
- 1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.
Based on Jane Street's 13F filing for Q4 2021, filed 15 Feb 2022.